[Controlled digitalis therapy].
D002792:Cholestyramine Resin / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use*; D004074:Digitoxin / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D010349:Patient Compliance; D010634:Phenobarbital / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use
D004071:Digitalis Glycosides; D002792:Cholestyramine Resin; D004077:Digoxin; D004074:Digitoxin; D011802:Quinidine; D012293:Rifampin; D010634:Phenobarbital
Die kontrollierte Digitalistherapie.